Ocugen Completes $115M Convertible Note Offering, Repays Debt, Boosting Cash to $99M

summarizeSummary

Ocugen completed a $115 million convertible note offering, generating $99.5 million in net proceeds, which were used to repay $32.7 million in debt and boost its pro forma cash to $99.0 million, addressing prior liquidity concerns.

check_boxKey Events

• Convertible Note Offering Completed

  Ocugen completed its private offering of $115.0 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034, following the pricing announcement on May 5, 2026.

• Substantial Net Proceeds Received

  The company received approximately $99.5 million in net proceeds from the offering after deducting discounts, commissions, and estimated expenses.

• Existing Debt Repaid

  Approximately $32.7 million of the net proceeds was used to fully repay and terminate the outstanding Loan and Security Agreement with Avenue Venture Opportunities Fund.

• Pro Forma Cash Position Strengthened

  Ocugen estimates an as-adjusted cash, cash equivalents, and restricted cash balance of $99.0 million as of March 31, 2026, significantly improving its financial liquidity.

auto_awesomeAnalysis

Ocugen has completed its previously announced private offering of $115 million in convertible senior notes, securing approximately $99.5 million in net proceeds. This substantial capital raise is critical for the company, especially in light of its prior 'going concern' warning, and significantly extends its cash runway. A portion of the proceeds, $32.7 million, was used to fully repay an existing loan agreement, strengthening the balance sheet. The notes are convertible at a premium of 45% over the May 4, 2026 stock price, indicating institutional confidence in a higher future valuation. However, initial conversions will be cash-settled until shareholder approval is obtained to issue the full number of common shares, which the company is committed to seeking by September 30, 2026.